Regulation of MHC I Molecules in Glioblastoma Cells and the Sensitizing of NK Cells
Immunotherapy has been established as an important area in the therapy of malignant diseases. Immunogenicity sufficient for immune recognition and subsequent elimination can be bypassed by tumors through altered and/or reduced expression levels of major histocompatibility complex class I (MHC I) mol...
Saved in:
Main Authors: | Timo Burster (Author), Fabian Gärtner (Author), Christiane Bulach (Author), Anuar Zhanapiya (Author), Adrian Gihring (Author), Uwe Knippschild (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Camostat Does Not Inhibit the Proteolytic Activity of Neutrophil Serine Proteases
by: Akmaral Assylbekova, et al.
Published: (2022) -
Hematopoietic Cell Transplantation for MHC Class II Deficiency
by: Su Han Lum, et al.
Published: (2019) -
Indolent NK cell proliferative lesion mimicking NK/T cell lymphoma in the gallbladder
by: Su Hyun Hwang, et al.
Published: (2016) -
Reuse of Molecules for Glioblastoma Therapy
by: Abigail Koehler, et al.
Published: (2021) -
MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells
by: Zélia Silva, et al.
Published: (2020)